Home › Acute Myeloid Leukemia › Oregon › Beaverton
Acute Myeloid Leukemia clinical trials in Beaverton, OR
3 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Beaverton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Providence Newberg Medical Center, Newberg · 15 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Providence Newberg Medical Center, Newberg · 15 mi away
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Providence Newberg Medical Center, Newberg · 15 mi away
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX88 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Baldwin Park, CA41 studies
- Seattle, WA40 studies
- Durham, NC34 studies
- Columbus, OH34 studies
- Philadelphia, PA33 studies
- Atlanta, GA30 studies
- Tampa, FL30 studies
- Chicago, IL27 studies
- Los Angeles, CA25 studies
Other studies in Beaverton
- Non-Small Cell Lung Cancer8 studies
- Lung Cancer8 studies
- Breast Cancer6 studies
- Ovarian Cancer5 studies
- Prostate Cancer5 studies
- Colorectal Cancer5 studies
- Bladder Cancer4 studies
- Endometrial Cancer4 studies
- Cancer (all types)3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Urothelial (Transitional Cell) Carcinoma3 studies
- Diffuse Large B-Cell Lymphoma3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.